KRAS and non-small cell lung carcinoma: However, real‐world data from the Indian subcontinent and analogous to other biomarker‐driven processes in NSCLC such as EGFR (Epidermal growth factor receptor), ALK (Anaplastic lymphoma kinase), and KRAS also show some distinct differences from the Western population, hence warrants comprehensive reporting of these findings.